WallStreetZen

NYSE: LIN
Linde Plc Stock Forecast, Predictions & Price Target

Analyst price target for LIN

Based on 11 analysts offering 12 month price targets for Linde Plc.
Min Forecast
$216.00-16.31%
Avg Forecast
$273.00+5.78%
Max Forecast
$320.00+23.99%

Should I buy or sell LIN stock?

Strong Buy
Strong Buy
11 analysts 84.62%
Buy
0 analysts 0%
Hold
2 analysts 15.38%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Forecast return on equity

Is LIN forecast to generate an efficient return?
Company
13.54%
Industry
32.51%
Market
62.25%
LIN's Return on Equity is forecast to be low in 4 years (13.54%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is LIN forecast to generate an efficient return on assets?
Company
7.17%
Industry
10.46%
Market
19.66%
LIN is forecast to generate lower Return on Assets (7.17%) than the US Specialty Chemicals industry average (10.46%)
Forecast

LIN earnings per share forecast

What is LIN's earnings per share in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$9.16+116.99%
Avg 2 year Forecast
$10.15+140.62%
Avg 3 year Forecast
$10.90+158.29%
LIN's earnings are forecast to grow at an exceptional rate of 37.75% per year
Forecast

LIN revenue forecast

What is LIN's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$28.7B+5.94%
Avg 2 year Forecast
$30.0B+11.01%
Avg 3 year Forecast
$31.5B+16.59%
LIN's revenue is forecast to grow at a rate of 5.17% per year, which is not exceptional
Forecast

LIN earnings growth forecast

How is LIN forecast to perform vs Specialty Chemicals companies and vs the US market?
Company
37.75%
Industry
26.46%
Market
20.47%
LIN's earnings are forecast to grow faster (37.75% per year) than the US Specialty Chemicals industry average (26.46%)
Forecast
LIN's earnings are forecast to grow faster (37.75% per year) than the US market average (20.47%)
Forecast
LIN's earnings are forecast to grow faster (37.75% per year) than the risk-free savings rate (1.1%)
Forecast

LIN revenue growth forecast

How is LIN forecast to perform vs Specialty Chemicals companies and vs the US market?
Company
5.17%
Industry
5.73%
Market
14.48%
LIN's revenues are forecast to grow slower (5.17% per year) than the US Specialty Chemicals industry average (5.73%)
Forecast
LIN's revenues are forecast to grow slower (5.17% per year) than the US market average (14.48%)
Forecast

Linde Stock Forecast FAQ

Is Linde Stock a good buy in 2020, according to Wall Street analysts?

The consensus among 13 Wall Street analysts covering (NYSE: LIN) stock is to Strong Buy LIN stock.

Out of 13 analysts, 11 (84.62%) are recommending LIN as a Strong Buy, 0 (0%) are recommending LIN as a Buy, 2 (15.38%) are recommending LIN as a Hold, 0 (0%) are recommending LIN as a Sell, and 0 (0%) are recommending LIN as a Strong Sell.

What is LIN's Price Target?

According to 11 Wall Street analysts that have issued a 1 year LIN price target, the average LIN price target is $273.00, with the highest LIN stock price forecast at $320.00 and the lowest LIN stock price forecast at $216.00.

On average, Wall Street analysts predict that Linde's share price could reach $273.00 by Jan 8, 2022. The average Linde stock price prediction forecasts a potential upside of 5.78% from the current LIN share price of $258.09.

What is LIN's earnings growth forecast for 2021-2023?

(NYSE: LIN) Linde's forecast annual earnings growth rate of 37.75% is forecast to beat the US Specialty Chemicals industry's average forecast earnings growth rate of 26.46%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 20.47%.

Linde's earnings in 2020 is $2,242,000,000.On average, 7 Wall Street analysts forecast LIN's earnings for 2021 to be $4,810,774,349, with the lowest LIN earnings forecast at $4,691,465,086, and the highest LIN earnings forecast at $4,990,920,304. On average, 5 Wall Street analysts forecast LIN's earnings for 2022 to be $5,334,505,765, with the lowest LIN earnings forecast at $5,017,188,306, and the highest LIN earnings forecast at $5,778,960,352.

In 2023, LIN is forecast to generate $5,726,424,349 in earnings, with the lowest earnings forecast at $5,726,424,349 and the highest earnings forecast at $5,726,424,349.

What is LIN's revenue growth forecast for 2021-2023?

(NYSE: LIN) Linde's forecast annual revenue growth rate of 5.17% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.48%.

Linde's revenue in 2020 is $27,051,000,000.On average, 5 Wall Street analysts forecast LIN's revenue for 2021 to be $15,055,322,291,749, with the lowest LIN revenue forecast at $14,706,639,787,790, and the highest LIN revenue forecast at $15,516,508,545,120. On average, 5 Wall Street analysts forecast LIN's revenue for 2022 to be $15,775,587,743,461, with the lowest LIN revenue forecast at $15,385,730,672,354, and the highest LIN revenue forecast at $16,122,322,212,420.

In 2023, LIN is forecast to generate $16,569,855,409,280 in revenue, with the lowest revenue forecast at $16,569,855,409,280 and the highest revenue forecast at $16,569,855,409,280.

What is LIN's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: LIN) Linde's current Earnings Per Share (EPS) is $4.22. On average, analysts forecast that LIN's EPS will be $9.16 for 2021, with the lowest EPS forecast at $8.93, and the highest EPS forecast at $9.50. On average, analysts forecast that LIN's EPS will be $10.15 for 2022, with the lowest EPS forecast at $9.55, and the highest EPS forecast at $11.00. In 2023, LIN's EPS is forecast to hit $10.90 (min: $10.90, max: $10.90).

What is LIN's forecast return on equity (ROE) for 2021-2024?

(NYSE: LIN) forecast ROE is 13.54%, which is considered weak.

What is LIN's forecast return on assets (ROA) for 2021-2024?

(NYSE: LIN) forecast ROA is 7.17%, which is lower than the forecast US Specialty Chemicals industry average of 10.46%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics